参考文献/References:
[1] Zhuo Z, Li F, Chen X, et al.Mycoplasma pneumonia combined with pulmonary infarction in a child[J]. Int J Clin Exp Med,2015,8(1):1482-1486.[2] Cilloniz C, Torres A, Niederman M, et al.Community-acquired pneumonia related to intracellular pathogens[J]. Intensive Care Med,2016,42(9):1374-1386.[3] Zhang Y, Zhou Y, Li S, et al.The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in Children[J]. PLoS One,2016,11(5):e156465.[4] 田恬,赵文静,高颂轶,等.甲泼尼龙联合阿奇霉素治疗儿童肺炎支原体大叶性肺炎的疗效[J]. 药物评价研究,2018,41(1):126-129.[5] 曹效红.甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性分析[J]. 国际医药卫生导报,2016,22(12):1745-1748.[6] 王浩,杨静容,欧静琳.甲泼尼龙联合阿奇霉素治疗RMPP患儿的临床效果[J]. 中南医学科学杂志,2016,44(04):442-446.[7] Shan L S, Liu X, Kang X Y, et al.Effects of methylpredniso-lone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children[J]. World J Pediatr,2017,13(4):321-327.[8] Gong L, Xu L, Diao M, et al.Clinical effect of treating secondary asthma attacks of children Mycoplasma pneumoniae with combined therapy of montelukast and azithromycin[J]. Eur Rev Med Pharmacol Sci,2016,20(24):5256-5260.